Compile Data Set for Download or QSAR
maximum 50k data
Found 19 Enz. Inhib. hit(s) with all data for entry = 9839
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492870(US10981882, Example 18)
Affinity DataIC50:  6nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492871(US10981882, Example 19)
Affinity DataIC50:  12nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492869(US10981882, Example 17)
Affinity DataIC50:  15nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492675(US10981882, Example 1)
Affinity DataIC50:  16nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492856(US10981882, Example 4)
Affinity DataIC50:  22nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492833(US10981882, Example 3)
Affinity DataIC50:  38nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492863(US10981882, Example 11)
Affinity DataIC50:  43nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492857(US10981882, Example 5)
Affinity DataIC50:  45nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492798(US10981882, Example 2)
Affinity DataIC50:  46nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492858(US10981882, Example 6)
Affinity DataIC50:  48nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492860(US10981882, Example 8)
Affinity DataIC50:  51nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492862(US10981882, Example 10)
Affinity DataIC50:  59nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492864(US10981882, Example 12)
Affinity DataIC50:  60nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492868(US10981882, Example 16)
Affinity DataIC50:  63nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492861(US10981882, Example 9)
Affinity DataIC50:  64nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492865(US10981882, Example 13)
Affinity DataIC50:  72nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492859(US10981882, Example 7)
Affinity DataIC50:  74nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492867(US10981882, Example 15)
Affinity DataIC50:  83nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Shanghai Joyu Pharmatech

US Patent
LigandPNGBDBM492866(US10981882, Example 14)
Affinity DataIC50:  108nMAssay Description:IDO1 enzymatic assay was carried out in a reaction mixture (500 μL/well) containing 50 mmol/L potassium phosphate buffer, 400 μg/mL catalas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent